Blockchain Registration Transaction Record

ADAP Advocacy Exposes 340B Program's Failure to Deliver Charity Care

ADAP Advocacy releases new 340B infographic exposing program's $100B growth amid declining charity care and rising patient debt. Download now.

This news matters because the 340B Drug Pricing Program was designed to extend federal resources and improve patient care, but its unchecked growth—over $100 billion in purchases in 2025—has not translated into better charity care. Instead, charity care is declining, executive compensation is rising, and patient medical debt is exploding. With more than 42,000 covered entities and 32,000 pharmacies involved, the program's inefficiencies directly affect vulnerable patients, especially those living with HIV/AIDS who rely on ADAPs. As Congress and policymakers consider reforms, this infographic provides critical evidence that the 340B program may be failing its core mission, making it essential reading for advocates, healthcare providers, and patients.